脓毒症中肠上皮细胞迁移的调控因素
该研究用野生型、转基因和基因敲除小鼠,在盲肠结扎穿孔(CLP)前后注射5-溴-2'-脱氧尿苷(BrdU)标记S期细胞,于预定终点处死,测定增殖细胞沿隐窝-绒毛单位迁移的距离。结果显示脓毒症后24至96小时肠上皮细胞迁移率下降;假手术组6天后绒毛上检测不到BrdU,而脓毒症组10天后仍可检测到BrdU阳性细胞。脓毒症降低隐窝增殖,使CLP后注射BrdU(增殖减少)的小鼠迁移慢于CLP前注射BrdU(增殖正常)的小鼠;肠道特异性过表达Bcl-2减少凋亡可防止脓毒症所致的肠上皮细胞迁移减慢,而JAM-A基因缺失加重肠道高通透性反而增加迁移。
要点
- 脓毒症后24至96小时小鼠肠上皮细胞迁移率下降。
- 假手术组6天后绒毛上检测不到BrdU,脓毒症组10天后仍可检测到BrdU阳性细胞。
- 脓毒症降低隐窝增殖,CLP后注射BrdU(增殖减少)的小鼠迁移慢于CLP前注射BrdU(增殖正常)的小鼠。
- 肠道特异性过表达Bcl-2减少凋亡,可防止脓毒症诱导的肠上皮细胞迁移减慢。
- JAM-A基因缺失加重肠道高通透性,反而增加肠上皮细胞迁移。
适用人群与场景
- 野生型、转基因和基因敲除小鼠,用于研究脓毒症对肠上皮细胞迁移的影响。
研究设计与关键结果
- 研究类型为动物实验,使用野生型、转基因和基因敲除小鼠,在盲肠结扎穿孔(CLP)前后注射BrdU标记S期细胞,于预定终点处死测定增殖细胞沿隐窝-绒毛单位迁移的距离。
- 脓毒症后24至96小时肠上皮细胞迁移率下降。
- 假手术组6天后绒毛上检测不到BrdU(所有细胞已迁移全长并脱落入肠腔),而脓毒症组10天后仍可检测到BrdU阳性细胞。
- 脓毒症降低隐窝增殖,CLP后注射BrdU(增殖减少)的小鼠迁移慢于CLP前注射BrdU(增殖正常)的小鼠。
- 肠道特异性过表达Bcl-2减少凋亡,可防止脓毒症诱导的肠上皮细胞迁移减慢。
- JAM-A基因缺失加重肠道高通透性,反而增加肠上皮细胞迁移。
证据类型、等级与局限
- 证据类型:动物实验(野生型、转基因和基因敲除小鼠)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该动物实验提示脓毒症减慢肠上皮细胞迁移,肠增殖、凋亡和通透性均影响迁移时间,可经遗传和药理靶向;原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The gut is a continuously renewing organ, with cell proliferation, migration, and death occurring rapidly under basal conditions. As the impact of critical illness on cell movement from crypt base to villus tip is poorly understood, the purpose of this study was to determine how sepsis alters enterocyte migration. Wild-type, transgenic, and knockout mice were injected with 5-bromo-2'deoxyuridine (BrdU) to label cells in S-phase before and after the onset of cecal ligation and puncture and were sacrificed at predetermined endpoints to determine distance proliferating cells migrated up the crypt-villus unit. Enterocyte migration rate was decreased from 24 to 96 h after sepsis. BrdU was not detectable on villi 6 days after sham laparotomy, meaning all cells had migrated the length of the gut and been exfoliated into its lumen. However, BrdU positive cells were detectable on villi 10 days after sepsis. Multiple components of gut integrity altered enterocyte migration. Sepsis decreased crypt proliferation, which further slowed enterocyte transit as mice injected with BrdU after the onset of sepsis (decreased proliferation) had slower migration than mice injected with BrdU before the onset of sepsis (normal proliferation). Decreasing intestinal apoptosis via gut-specific overexpression of Bcl-2 prevented sepsis-induced slowing of enterocyte migration. In contrast, worsened intestinal hyperpermeability by genetic deletion of JAM-A increased enterocyte migration. Sepsis therefore significantly slows enterocyte migration, and intestinal proliferation, apoptosis and permeability all affect migration time, which can potentially be targeted both genetically and pharmacologically.
参考来源
- Meng M, Klingensmith NJ, Liang Z, et al. Regulators of Intestinal Epithelial Migration in Sepsis. Shock. 2019. PMID: 29424793. doi:10.1097/SHK.0000000000001117
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。